Results 21 to 30 of about 73,164 (195)

Antihypertensive medication use during pregnancy in a real-world cohort of patients diagnosed with a hypertensive disorder of pregnancy

Frontiers in Cardiovascular Medicine, 2023
Hypertensive disorders of pregnancy (HDP) are rising in prevalence and associated with adverse maternal and infant health outcomes. Current guidelines recommend labetalol, nifedipine, and methyldopa as acceptable first-line agents to treat HDP in ...
Julian E. Garcia, Ian R. Mulrenin, Anh B. Nguyen, Matthew S. Loop, Matthew S. Loop, Melissa A. Daubert, Rachel Urrutia, Craig R. Lee   +7 more
doaj   +1 more source

Comparative effectiveness of first-line antihypertensive drug classes on the maintenance of estimated glomerular filtration rate (eGFR) in real world primary care

Scientific Reports, 2023
Renin-angiotensin system inhibitors (RASi), particularly angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs), are commonly used in the treatment of hypertension and are recommended for kidney protection ...
Qiao Gao, Ngiap Chuan Tan, Mong Li Lee, Wynne Hsu, Jason Choo   +4 more
doaj   +1 more source

Pooled mean differences for the outcomes of systolic blood pressure changes in patients with hypertension treated with a triple combination of rosuvastatin plus two antihypertensive agents.

, 2021
Pooled mean differences for the outcomes of systolic blood pressure changes in patients with hypertension treated with a triple combination of rosuvastatin plus two antihypertensive agents.
Sungjae Lee (5962706), Seungwon Yang (521667), Min Jung Chang (3173520)   +2 more
core   +1 more source

Combination therapy in the treatment of hypertension

Drugs in Context, 2018
Hypertension is a major preventable risk factor for atherosclerosis and ischemic heart disease. Although modern and effective antihypertensive drugs are available, most patients remain with a suboptimal blood pressure control.
Alberto Francisco Rubio-Guerra
doaj   +1 more source

Pooled mean differences for the outcomes of diastolic blood pressure changes in patients with hypertension treated with a triple combination of rosuvastatin plus two antihypertensive agents.

, 2021
Pooled mean differences for the outcomes of diastolic blood pressure changes in patients with hypertension treated with a triple combination of rosuvastatin plus two antihypertensive agents.
Sungjae Lee (5962706), Seungwon Yang (521667), Min Jung Chang (3173520)   +2 more
core   +1 more source

No influence of antihypertensive agents on plasma free metanephrines [PDF]

, 2016
Background: Hypertension can be the predominant sign of pheochromocytoma (PCC) and sympathetic paraganglioma (sPGL) and screening for PCC/sPGL is often performed in patients who are already being treated with antihypertensive agents. There is very little
Links, Thera P., Horst-Schrivers, van der, Anouk, de Jong, Wilhelmina H. A., van Faassen, Martijn; id_orcid, Kema, Ido P., Osinga, Thamara E., Dullaart, Robin P. F., Kema, Ido P.; id_orcid, Kerstens, Michiel N., van Faassen, Martijn   +9 more
core   +1 more source

Gingival Enlargement in Antihypertensive Medication

Journal of Nepal Medical Association, 2009
Introduction: Drug-induced gingival enlargement is a well documented side effect with the use of phenytoin, cyclosporine and calcium channel blockers. The prevalence of gingival enlargement induced by calcium channel blockers is uncertain.
Shaili Pradhan, P Mishra
doaj   +1 more source

Patrones de uso de antihipertensivos en 11.947 pacientes colombianos.

Biomédica: revista del Instituto Nacional de Salud, 2002
El 12,6% de la población colombiana mayor de 15 años es hipertensa. Para conocer sobre el manejo farmacológico de la hipertensión y su comorbilidad, se desarrolló este estudio en 11.947 hipertensos adultos de ambos sexos, en tratamiento durante más de 3 ...
Carlos A. Isaza, Franciso J. Osorio, Giovanny Mesa, Juan C. Moncada   +3 more
doaj   +1 more source

The risk of acute myocardial infarction after discontinuation of antihypertensive agents [PDF]

, 2015
Background: Sudden discontinuation of some antihypertensive agents such as beta-blockers and centrally acting antihypertensive agents are associated with increased risk of acute coronary events.
Klungel, Olaf H., Souverein, Patrick C., De Groot, Mark C.H., Alharbi, Fawaz F., Der Zee, Anke H Maitland-Van, De Boer, Anthonius   +5 more
core  

Up-to-Date Aspects of Antihypertensive Therapy from the Viewpoint of Cardioand Nephroprotective Action: Olmesartan

Антибиотики и Химиотерапия, 2020
The literature data on possible optimization of the arterial hypertension management with organoprotective antihypertensive agents are reviewed. Olmesartan is one of the most thoroughly investigated agents blocking the receptors to angiotensin-II that ...
A. G. Evdokimova, Yu. V. Ryzhova
doaj